Merck gets FDA Breakthrough Therapy designation for sac-TMT
Merck (NYSE:MRK) said the FDA has granted Breakthrough Therapy designation for its antibody drug conjugate sacituzumab ...
MRK: Sac-TMT Gets FDA Breakthrough Therapy Designation For EGFR-mutated Advanced Or Metastatic NSCLC
Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...
Cure Today10d
FDA Grants Breakthrough Therapy Designation to Sac-TMT for Some with NSCLC
The FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for patients with advanced or metastatic ...
Rhetan TMT Set To Sign Lease Deed For Land For 2 MW Solar Power Project In Banaskantha
In a significant development in its solar power initiative, Rhetan TMT Limited, a leading name in steel manufacturing, has ...